Stock CRGX CARGO THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News CARGO Therapeutics, Inc.

Equities

CRGX

US14179K1016

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-18 EDT 		5-day change 1st Jan Change
15.43 USD -3.08% Intraday chart for CARGO Therapeutics, Inc. -11.42% -33.35%
06-04 CARGO Therapeutics, Inc. Announces the Appointment of Jane Pritchett Henderson as Independent Director CI
05-28 CARGO Therapeutics, Inc. announced that it expects to receive $110.007 million in funding CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director
GL
CARGO Therapeutics, Inc. Announces the Appointment of Jane Pritchett Henderson as Independent Director
CI
CARGO Therapeutics to Participate in Upcoming Investor Conferences
GL
CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing
GL
CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing
AQ
CARGO Therapeutics, Inc. announced that it expects to receive $110.007 million in funding
CI
Truist Securities Cuts Price Target on CARGO Therapeutics to $32 From $34, Maintains Buy Rating
MT
CARGO Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
CARGO Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GL
Certain Common Stock of CARGO Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 8-MAY-2024.
CI
Certain Stock Options of CARGO Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 8-MAY-2024.
CI
CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors
GL
CARGO Therapeutics, Inc. Appoints Kapil Dhingra to Board of Directors
CI
Cargo Therapeutics Reports Q4 Net Loss
MT
CARGO Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
CARGO Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
GL
CARGO Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
CARGO Therapeutics, Inc.(NasdaqGS:CRGX) added to S&P Global BMI Index
CI
CARGO Therapeutics, Inc.(NasdaqGS:CRGX) added to S&P Biotechnology Select Industry Index
CI
CARGO Therapeutics to Participate in the 44th Annual Cowen Healthcare Conference
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CRGX Stock
  4. News CARGO Therapeutics, Inc.